Award notice Supplies
Farmaceutische specialiteiten G-CSF
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- Vereniging iris-Aankopen
Saint-Gilles - Place of performance
- 1090 Bruxelles\Brussel, Brussels-Capital
- Amount awarded
- €919,704 excl. VAT
- Planned end of contract
- 21 August 2028
likely re-tender around February 2028 - Bids received
- 3
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 23 August 2024
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Spécialités pharmaceutiques G-CSF
Awarded to
- ACCORD HEALTHCARE BCE/KBO 0841.940.204
2 lots
- spécialité pharmaceutique à base de filgrastim - code ATC L03AA02
- Spécialité pharmaceutique à base de pegfilgrastim - code ATC L03AA13 ou lipegfilgrastim - code ATC L03AA14
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Farmaceutische producten op basis van piperacilline/tazobactam, flucloxacilline, linezolid, benzylpenicilline (natrium), vancomycine (hydrochloride), ceftazidime en meropenem (trihydraat). Vereniging iris-Aankopen · 15 April 2024 |
Viatris BV SRL FRESENIUS KABI NV SANDOZ SA AUROBINDO SA |
€556,851 |
| Raamovereenkomst: aankoop CPT intra-vitreale injectie vzw Jessa Ziekenhuis · 22 October 2026 |
DE CEUNYNCK MEDICAL | €604,000 |
| Raamovereenkomst voor het leveren van Tocilizumab IV AZ Oudenaarde · 16 October 2026 |
Fresenius Kabi | €1,200,000 |
| Leveren van orale antibiotica UZ Leuven · 16 October 2026 |
Pfizer Viatris Arega Pharma EUMEDICA |
€1,032,354 |
| Leveren van parenterale en inhalatie antibiotica UZ Leuven · 12 October 2026 |
sandoz Viatris Fresenius Kabi ACCORD HEALTHCARE |
€26,847,462 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 507742-2024.